Alpha-fetoprotein producing gastric cancer  by Tsung, Swei H.
Journal of the Formosan Medical Association (2016) 115, 130e131Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.j fma-onl ine.comCORRESPONDENCEAlpha-fetoprotein producing gastric cancer
Swei H. Tsung*Department of Pathology, St Mary’s Hospital, Loudong, Yilan, TaiwanReceived 12 November 2014; received in revised form 12 January 2015; accepted 18 January 2015Alpha-fetoprotein producing gastric cancer (AFP-GC) has
been reported all over the world, but mostly in Asia. The
reported incidence was 6.63% and 1.5e3% in China 1 and
Japan,2 respectively. To my knowledge, there was only one
case reported in Taiwan. Herein, I wish to share my expe-
rience of the six cases of AFP-GC that I encountered during
my career. The brief clinical data of these cases are sum-
marized in Table 1.
These six patients were all male, with their ages ranging
from 58 years to 82 years. The serum levels of AFP ranged
from 174 ng/mL to 74,904 ng/mL. All of them, except the
first patient, had lymph node and liver metastasis at the
time of diagnosis. Five patients died within 6 months of
diagnosis. One patient who underwent gastrectomy was
living well 2 years after surgery.Table 1 Clinical data of six patients with AFP-GC.
Case number/
age/sex
Tumor site and
procedure
Serum level o
AFP (ng/mL)
1/78/M Cardia, gastrectomy 490
2/59/M Body, Bx 74,901
3/79/M Antrum, Bx 35,350
4/61/M Pylorus, Bx 1306
5/80/M Body, Bx 174
6/82/M Pylorus, Bx 23,041
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http://dx.doi.org/10.1016/j.jfma.2015.01.010
0929-6646/Copyright ª 2015, Elsevier Taiwan LLC & Formosan MedicalThe morphological spectrum of AFP-GC includes hep-
atoid adenocarcinoma, intestinal type, and signet ring cell
type. The criteria for diagnosing AFP-GC depend on positive
staining of the primary lesion by immunohistochemical
methods.
AFP-GC has been considered as having an unfavorable
long-term survival rate due in part to the higher incidence of
liver metastasis and lymphovascular invasion. The cellular
and molecular mechanisms responsible for its poor prognosis
are not clearly understood. An early report indicated that
AFP has a suppressive effect on lymphocyte transformation.3
Another report indicated that AFP can enhance proliferative
activity and increase angiogenesis due to positive expression
of vascular endothelial growth factor (VEGF).4 In a study in
2000,5 it was found that hepatocyte growth factor (HGF) andf Lymph node
hepatic metastasis
Follow up
No Alive with no metastasis
Yes DOD
Yes DOD
Yes DOD
Yes DOD
Yes DOD
DOD Z died of disease.c-met expression was higher in AFP-GC than that in AFP
negative gastric cancer. Through the HGF and c-met
pathway, AFP promoted tumor growth.
It has been well documented that AFP-GC is quite
different from the usual type of gastric cancer. It is justifiedAssociation. All rights reserved.
Correspondence 131to order serum AFP on all patients with gastric cancer
because of its prognostic significance. To develop effective
multimodal therapy against AFP-GC, a better understanding
of the characteristics of AFP-GC at the cellular and mo-
lecular levels is important.
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